Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
about
Biomarkers in pancreatic adenocarcinoma: current perspectivesExosomes genetic cargo in lung cancer: a truly Pandora's boxAnalysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patientsNovel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancyProfiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer.Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter.Pancreatic cancer: Current status and Challenges.
P2860
Q28072309-84525CA0-8C4A-4181-BBC5-D3FEB0E719D1Q28079149-962133FD-C014-4C94-B40C-151035010AE1Q40444196-7009C4CE-CF04-4874-9713-E9AEA173DB45Q40492081-800530AD-AE5A-42BB-98E4-07E2BB1E7362Q40495250-3B078DC2-1215-44EA-A9C3-61E00BA97E2CQ41347759-7BBF1CFD-9320-4669-A67C-ED66BC2D2BCAQ41524917-47126080-C37E-4183-9AAA-808A5E4DB968Q41624551-2C7EE157-CE30-4823-ADC3-B2EA4A2281F1Q45901388-F819FC85-E3D6-4F8A-9D6F-61A54C80602DQ47146321-2852E324-25B2-4220-B34A-571AB9C28850Q47562193-BDD7F4FF-153A-4328-9923-2DE64EFF0C6AQ48163413-2D392494-901A-4784-9045-A2BF8613E117Q48499391-B5B928A6-A3DD-4036-8EEB-96DBE17C1C6FQ49924982-7EF6393B-D9FB-4CE8-AC06-FC338F7F998FQ50195669-F1301339-1567-4F11-8585-4B7DFCB0DBD8
P2860
Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of circulatin ...... section for pancreatic cancer.
@en
Prognostic value of circulatin ...... section for pancreatic cancer.
@nl
type
label
Prognostic value of circulatin ...... section for pancreatic cancer.
@en
Prognostic value of circulatin ...... section for pancreatic cancer.
@nl
prefLabel
Prognostic value of circulatin ...... section for pancreatic cancer.
@en
Prognostic value of circulatin ...... section for pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Prognostic value of circulatin ...... section for pancreatic cancer.
@en
P2093
Eiso Hiyama
Kenichiro Uemura
Naoto Hadano
Naoya Nakagawa
Naru Kondo
Taijiro Sueda
Yasusi Hashimoto
Yoshiaki Murakami
P2860
P2888
P356
10.1038/BJC.2016.175
P407
P577
2016-06-09T00:00:00Z